Skip to main content
Roberto Bolli, MD, Cardiology, Louisville, KY

RobertoBolliMD

Cardiology Louisville, KY

Adult Congenital Heart Disease

Professor, Medicine, University of Louisville School of Medicine

Are you Dr. Bolli?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 39 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    201 Abraham Flexner Way
    1001
    Louisville, KY 40202
    Phone+1 502-587-4500
    Fax+1 502-587-4146

Summary

  • Dr. Roberto Bolli, MD is a cardiologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky and Texas. He is affiliated with UofL Health - UofL Hospital and is a Professor at University of Louisville School of Medicine.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1981 - 1983
  • University of Perugia Faculty of Medicine
    University of Perugia Faculty of MedicineClass of 1976
  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Cardiovascular Disease

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 1995 - 2025
  • TX State Medical License
    TX State Medical License 1984 - 1995
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1991
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Years After Brigham-Harvard Scandal, U.S. Pours Millions into Tainted Stem-Cell Field
    Years After Brigham-Harvard Scandal, U.S. Pours Millions into Tainted Stem-Cell FieldJune 21st, 2022
  • Cell Therapy Improves Outcomes for Heart Failure Patients, Clinical Trial Shows
    Cell Therapy Improves Outcomes for Heart Failure Patients, Clinical Trial ShowsJune 14th, 2021
  • Clinical Trial at UofL Shows Cell Therapy Improves Outcomes in Heart Failure
    Clinical Trial at UofL Shows Cell Therapy Improves Outcomes in Heart FailureJune 14th, 2021
  • Join now to see all

Grant Support

  • University Of Louisville Regional Clinical Center For The CctrnNational Heart, Lung, And Blood Institute2012
  • Preclinical Consortium To Facilitate Translation Of Cardioprotective TherapiesNational Heart, Lung, And Blood Institute2010–2011
  • Protection Of Ischemic MyocardiumNational Heart, Lung, And Blood Institute2005–2011
  • Gene Therapy To Achieve Permanent CardioprotectionNational Heart, Lung, And Blood Institute2005–2009
  • Oxygen Radicals And Cardiac Adaptations To IschemiaNational Heart, Lung, And Blood Institute2000–2009
  • Hematopoietic Stem Cell Therapy For Myocardial RegenerationNational Heart, Lung, And Blood Institute2007
  • Mechanisms Of CardioprotectionNational Heart, Lung, And Blood Institute2003–2007
  • Hematopoietic Stem Cell Therapy For Myocardial RegeneratNational Heart, Lung, And Blood Institute2004–2006
  • Molecular Basis Of PreconditioningNational Heart, Lung, And Blood Institute2001–2003
  • Oxygen Radicals And Postischemic DysfunctionNational Heart, Lung, And Blood Institute1995–2002
  • Oxygen Radicals And Cardiac Adaptations To IschemiaNational Heart, Lung, And Blood Institute1995–1999
  • Oxygen Radicals And Postischemic DysfunctionNational Heart, Lung, And Blood Institute1994
  • Oxygen Radicals And Post-Ischemic DysfunctionNational Heart, Lung, And Blood Institute1993
  • Role Of Oxygen Radicals In Postischemic DysfunctionNational Heart, Lung, And Blood Institute1989–1991

Professional Memberships